Prioritising access to cancer drugs

The cost of the HPV vaccine substantially impedes vaccination coverage in the Philippines because vaccine acceptance among Filipinos is highly dependent on affordable pricing.3 Increased government funding is essential. [...]we agree with Fundytus and colleagues1 that global collaborative efforts un...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The lancet oncology 2022-01, Vol.23 (1), p.e2-e2
Hauptverfasser:	Puyat, Corinna Victoria M, Eala, Michelle Ann B, Dee, Edward Christopher, Tantengco, Ourlad Alzeus G, Cruz, Anna Rominia D P, Faylona, Edgar A, Germar, Maria Julieta V, Sacdalan, Dennis L
Format:	Artikel
Sprache:	eng
Schlagworte:	Antineoplastic Agents - adverse effects Cervical cancer Cervix Disease prevention Health Services Accessibility Human papillomavirus Humans Neoplasms - drug therapy Vaccination Vaccines
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The cost of the HPV vaccine substantially impedes vaccination coverage in the Philippines because vaccine acceptance among Filipinos is highly dependent on affordable pricing.3 Increased government funding is essential. [...]we agree with Fundytus and colleagues1 that global collaborative efforts under strong UN and WHO leadership are necessary to increase accessibility and affordability of cancer medicines. Additionally, cancer control strategies designed for LMICs must be explored, such as the use of a single HPV vaccine dose to increase coverage against cervical cancer in a more affordable manner.5 We call on the global oncology community to take urgent action to improve cancer medicine accessibility worldwide.
ISSN:	1470-2045 1474-5488
DOI:	10.1016/S1470-2045(21)00637-9